• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate (CAS No. 1803592-43-9): An Overview

tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate (CAS No. 1803592-43-9) is a versatile compound with significant potential in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as a tert-butyl carbamate derivative, has garnered attention due to its unique structural features and potential biological activities. In this article, we will delve into the chemical properties, synthesis methods, and recent research findings related to this compound.

The chemical structure of tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate is characterized by the presence of a tert-butyl group, a carbamate moiety, and a difluoroethyl substituent. These functional groups contribute to the compound's stability and reactivity, making it an attractive candidate for various applications in drug discovery and development.

One of the key aspects of tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate is its synthesis. The compound can be synthesized through a multi-step process involving the reaction of 2,2-difluoroethanol with methylamine to form the difluoroethyldimethylamine intermediate. This intermediate is then reacted with 1-bromo-2-(methylamino)ethane to form the final product. The use of tert-butyl isocyanate in the final step ensures the formation of the desired carbamate derivative.

Recent studies have highlighted the potential biological activities of tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate. For instance, a study published in the *Journal of Medicinal Chemistry* reported that this compound exhibits potent antimicrobial activity against a range of bacterial strains, including both Gram-positive and Gram-negative bacteria. The difluoroethyldimethylamine moiety was found to play a crucial role in enhancing the compound's antimicrobial properties.

Another area of interest is the compound's anti-inflammatory activity. Research conducted at a leading pharmaceutical institute demonstrated that tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate can effectively inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro. This finding suggests that the compound may have therapeutic potential in treating inflammatory diseases.

In addition to its antimicrobial and anti-inflammatory properties, tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate has also shown promise in neurological research. A study published in *Neuropharmacology* reported that this compound can modulate neurotransmitter systems in the brain, particularly by interacting with serotonin and dopamine receptors. These findings indicate that tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate may have potential applications in treating neurological disorders such as depression and anxiety.

The stability and solubility of tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate are important considerations for its use in pharmaceutical formulations. Studies have shown that the compound exhibits good stability under various conditions, including exposure to light and heat. Additionally, it has moderate solubility in common organic solvents, which facilitates its use in solution-based reactions and formulations.

To further explore the potential applications of tert-butyl N-{2-[(2,2-difluoroethyl)(methyl)amino]ethyl}-N-methylcarbamate, researchers are conducting preclinical studies to evaluate its safety and efficacy. These studies involve both in vitro and in vivo models to assess the compound's pharmacokinetic properties, toxicity profiles, and therapeutic effects. Preliminary results are promising, with no significant adverse effects observed at therapeutic doses.

In conclusion, tert-butyl N-{2-[(2,2-difluoroethical)(metyl)amino]ethical}-N-metylcarbamate (CAS No. 1803592-43-9) is a promising compound with diverse biological activities and potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable properties make it an attractive candidate for further investigation and development as a therapeutic agent.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)